Abstract submission is now closed.
Late-breaking Abstract Submission: September 1 - 7, 2015
Late-breaking abstracts should contain new information that was not yet known or fully available by the general abstract submission deadline.
Abstract data must not have been published, prior to the ESGO 2015 Congress.
The late-breaking abstract submission is not an extension of the abstract submission deadline.
To view the full list of abstract topics, please click here
For instructions on how to prepare your abstract for submission, please click here
If you require further assistance, please contact the abstract department here
Young Investigators Oral Presentation
- An author submitting an abstract under the Young Investigators Oral Presentation category will be considered for oral or poster presentation should the abstract not be accepted for presentation in the Young Investigators Session
- An author for an abstract submitted under the Young Investigators Oral Presentation category must be a fellow/trainee OR 40 years of age or under (by October 24, 2015)
- Submission for the Young Invesigators session is now closed.
Accepted abstracts are now published in the Vol 25, Supplement 2, October 2015 online supplement to the International Journal of Gynecological Cancer and subsequently will be available through Medline.
- Accepted abstracts will be selected by the Scientific Programme Committee for either oral or poster presentation.
- You may indicate your preference when submitting your abstract; however, the committee’s decision is final.
Guidelines for submission of abstracts
- Please do not submit multiple copies of the same abstract
- ESGO does not accept encore abstracts
- Abstracts submitted by email, fax, etc. will not be accepted
Guidelines for preparation of abstracts
- Title of abstract must be in upper case letters
- Abstracts should contain no more than 250 words
- Abstracts should have no more than 20 authors
- Inclusion of images or tables will reduce the number of words allowed in the abstract body
- The abstracts should be as informative as possible. Abstracts should clearly state background and aims, methods, results and conclusions of the study
- Abstracts stating: “data will be discussed in the presentation” will not be accepted
- Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the first occurrence of the full word
- Use generic names of drugs. Express numbers as numerals
- You will receive an acceptance message after submission